4 Days. Dozens of Practice-Changing Insights.

The agenda will include a robust mix of clinically driven talks, engaging debates, and interactive case discussions in the field of hematologic malignancies. Each day will provide a deep dive into a particular therapeutic area.

October 13: LEUKEMIA DAY

Leukemia Day meeting brings together leading experts to explore advances across different types leukemias, including ALL, AML,CML, and related disorders. Through cutting-edge science, real-world insights, and evolving therapies, the program highlights personalized care, novel treatments, and strategies improving outcomes across the leukemia spectrum.

October 14: LYMPHOMA DAY

Lymphoma Day convenes leading experts to examine progress across Hodgkin and non-Hodgkin lymphomas, including DLBCL, follicular, mantle cell,andT-cell subtypes. Featuring cutting-edge science, immunotherapy, cellular therapies, and precision medicine, the program showcases innovative approaches shaping the future of lymphoma care.

October 15: MYELOMA DAY

Myeloma Day brings together global experts to explore advances across the myeloma continuum, from MGUS and smoldering disease to newly diagnosed and relapsed/refractory multiple myeloma. Featuring novel immunotherapies, cellular therapies, precision risk stratification, and evolving treatment strategies, the program highlights innovations shaping personalized care and improved patient outcomes.

October 16: CLL DAY

CLL Day brings together leading experts to examine the evolving landscape of chronic lymphocytic leukemia, from early disease and risk stratification to relapsed, refractory, and transformed CLL. Featuring advances in targeted therapies, non-covalent BTK inhibitors, CAR T-cell therapy, MRD-guided strategies, and Richter transformation, the program highlights personalized approaches improving outcomes across the CLL continuum.

FULL AGENDA COMING SOON!!!!!!